0001145549-23-015649.txt : 20230309 0001145549-23-015649.hdr.sgml : 20230309 20230309110157 ACCESSION NUMBER: 0001145549-23-015649 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 EFFECTIVENESS DATE: 20230309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SWISS HELVETIA FUND, INC. CENTRAL INDEX KEY: 0000813623 IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-05128 FILM NUMBER: 23718623 BUSINESS ADDRESS: STREET 1: C/O U.S. BANK GLOBAL FUND SERVICES STREET 2: 615 EAST MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 8007302932 MAIL ADDRESS: STREET 1: C/O U.S. BANK GLOBAL FUND SERVICES STREET 2: 615 EAST MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 FORMER COMPANY: FORMER CONFORMED NAME: SWISS HELVETIA FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: HELVETIA FUND INC DATE OF NAME CHANGE: 19900820 N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000813623 XXXXXXXX false false false N-2 Swiss Helvetia Fund, Inc. 811-05128 0000813623 549300HQZ0XPGTS5Q724 615 East Michigan Street Milwaukee 53202 US-WI US 18007302932 US Bancorp Fund Services 615 East Michigan Street Milwaukee 53202 18336121912 Fund administration and fund accounting data U.S. Bank, N.A. 1555 North River Center Drive Suite 302 Milwaukee 53212 8336121912 Custody data American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn 11219 8885560425 Transfer agent data N N N N-2 Y Gerald Hellerman N/A N Mortiz A. Sell N/A N Richard Dayan N/A N Andrew Dakos 004881082 Y Phillip F. Goldstein 005711842 N Stephanie Darling N/A 250 Pehle Avenue 7th Floor Saddle Brook 07663 XXXXXX N N N N N N Tait, Weller & Baker LLP 00445 N/A N N N N N SWISS HELVETIA FUND, INC. 549300HQZ0XPGTS5Q724 N N/A Y N Y N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4 (17 CFR 270.18f-4) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) N N N N Schroder Investment Management North America Inc. 801-15834 000105820 5493003P29LAPF3HFV10 N Schroder Investment Management North America Limited 801-37163 000106585 54930087VYMSIGK4TY26 Y GB N American Stock Transfer & Trust Company, LLC 84-00416 254900TS5EWP83BEOU02 N N N Intercontinental Exchange Inc. 5493000F4ZO33MV32P92 N N U.S. Bank National Association 6BYL5QZYBDK8S7L73M02 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N N U.S. Bancorp Fund Services, LLC 85-11357 N N N UBS ASSET MANAGEMENT (US) INC. 8-21901 000000583 N/A 3528.000000000000 CREDIT SUISSE SECURITIES (USA) LLC 8-00422 000000816 1V8Y6QCX6YMJ2OELII46 2483.000000000000 CITIGROUP GLOBAL MARKETS INC. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 1424.000000000000 MORGAN STANLEY & CO. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 1046.000000000000 ABN AMRO SECURITIES (USA) LLC 8-68398 000151796 549300FIFV1CB6HD9A14 861.000000000000 OPTIVER US LLC 8-66083 000128030 549300GSJ60SX9WHBZ61 748.000000000000 BERENBERG CAPITAL MARKETS LLC 8-68821 000156757 5493007EG0CYRKKG9L11 731.000000000000 GOLDMAN SACHS & CO. LLC 8-00129 000000361 FOR8UP27PHTHYVLBNG30 640.000000000000 PERSHING LLC 8-17574 000007560 ZI8Q1A8EI8LQFJNM0D94 587.000000000000 EXANE, INC. 8-49569 000041784 N/A 490.000000000000 14384.000000000000 0.000000000000 N 123683693.969425000000 Common stock The Swiss Helvetia Fund, Inc. N N Common stock N N N 0.700000000000 1.680000000000 7.560000000000 8.800000000000 true INTERNAL CONTROL RPT 2 swisshelvetia.htm SWISS HELVETIA CONTROLS LETTER

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

  

  

  

To the Stockholders and Board of Directors 

The Swiss Helvetia Fund, Inc. 

New York, NY 

  

  

In planning and performing our audit of the financial statements of The Swiss Helvetia Fund, Inc. (the “Fund”) as of and for the year ended December 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered its internal control over financial reporting, including control activities for safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we express no such opinion. 

  

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting.  In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls.  A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.  Such internal control includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements. 

  

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

  

A control deficiency exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis.  A significant deficiency is a control deficiency, or combination of control deficiencies, that adversely affects the company’s ability to initiate, authorize, record, process or report financial data reliably in accordance with accounting principles generally accepted in the United States of America such that there is more than a remote likelihood that a misstatement of the company’s annual or interim financial statements that is more than inconsequential will not be prevented or detected. A material weakness is a significant deficiency, or combination of significant deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected. 

  

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be significant deficiencies or material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls for safeguarding securities, which we consider to be material weaknesses, as defined above, as of December 31, 2022. 

  

This report is intended solely for the information and use of management, Stockholders and Board of Directors of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 

  

  

/s/ TAIT, WELLER & BAKER LLP 

  

TAIT, WELLER & BAKER LLP 

Philadelphia, Pennsylvania 

February 28, 2023